# Assessment of Combined CCM and ICD Device in HFrEF

Study · id `cardio:ct-nct05855135` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05855135](<https://clinicaltrials.gov/study/NCT05855135>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05855135

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05855135. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-17 (actual); primary completion 2025-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05855135, source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)
- Started: 2023-05-17 (actual) (ClinicalTrials.gov record NCT05855135, source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT05855135, source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05855135, source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05855135, source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05855135-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Assessment of Combined CCM and ICD Device in HFrEF
- Acronym: INTEGRA-D
- Condition: Heart Failure
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Implantable Defibrillator User
- Condition: CCM Therapy
- Condition: Non-ischemic Cardiomyopathy
- Condition: Ischemic Cardiomyopathy
- Condition: Sudden Cardiac Arrest
- Condition: Arrhythmias, Cardiac
- Condition: Ventricular Tachycardia
- Condition: Ventricular Fibrillation
- Intervention (Device): OPTIMIZER® Integra CCM-D System (Treatment Arm)
- Lead sponsor: Impulse Dynamics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Impulse Dynamics (`cardio:org-impulse-dynamics`)

## Provenance

Content hash: 227b616f509d2b72e0fb73541a986742c2ae1f8e724fbb552f844db58c546de9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
